Page last updated: 2024-12-07

podocarpic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Podocarpic acid is a naturally occurring diterpenoid compound found in various species of Podocarpus, a genus of coniferous trees. It has been studied for its diverse biological activities, including anti-inflammatory, antimicrobial, and anticancer properties. Its synthesis can be achieved through various methods, often involving multi-step reactions. Research on podocarpic acid is driven by its potential therapeutic applications, particularly in the areas of medicine and agriculture. The compound has shown promise in treating inflammatory conditions, inhibiting bacterial growth, and even displaying cytotoxic effects against certain cancer cell lines. Its structural features and biological properties make it an attractive target for drug discovery and development.'

podocarpic acid: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

podocarpic acid : An abietane diterpenoid lacking the isopropyl substituent with an aromatic C-ring and a hydroxy group at the 12-position. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID93017
CHEMBL ID421115
CHEBI ID8277
SCHEMBL ID160062
MeSH IDM0043066

Synonyms (43)

Synonym
12-hydroxypodocarpa-8,11,13-trien-16-oic acid
CHEBI:8277 ,
(1s,4as,10ar)-6-hydroxy-1,4a-dimethyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-1-carboxylic acid
(1s,4as,10ar)-1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-1,4a-dimethylphenanthrene-1-carboxylic acid
ACON0_000057
TIMTEC1_001673
einecs 227-706-3
podocarpa-8,11,13-trien-16-oic acid, 12-hydroxy- (van)
nsc 231784
1-phenanthrenecarboxylic acid, 1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-1,4a-dimethyl-, (1s-(1alpha,4aalpha,10abeta))-
ACON1_002112
MEGXP0_001903
5947-49-9
podocarpic acid
C09171
podocarpic acid, 98%
NCGC00142360-01
NCGC00142360-02
NCGC00142360-03
HMS1538M01
BRD-K22269939-001-02-2
BRD-K22269939-001-01-4
podocaric acid
CHEMBL421115 ,
bdbm50167696
LMPR0104120002
(1s,4as,10ar)-6-hydroxy-1,4a-dimethyl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylic acid
7k80g5z96y ,
unii-7k80g5z96y
(1s,4as,10ar)-6-hydroxy-1,4a-dimethyl-1,2,3,4,9,10,10a,4a-octahydrophenanthren ecarboxylic acid
AKOS015893995
CCG-208490
SCHEMBL160062
podocarpic acid [mi]
HY-N2318
CS-6114
podo-carpic acid
Q27108028
1-phenanthrenecarboxylic acid,1,2,3,4,4a,9,10,10a-octahydro-6-hydroxy-1,4a-dimethyl-,(1s,4as,10ar)-
F85483
MS-23898
DTXSID30878214
podocarpicacid

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Dehydroabietic acid and the oleoresin were the most toxic compounds followed by O-methylpodocarpic acid, whereas podocarpic acid and tea tree oil showed a lower level of toxicity."( Toxic effects of some conifer resin acids and tea tree oil on human epithelial and fibroblast cells.
Gref, R; Johansson, A; Söderberg, TA, 1996
)
0.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
abietane diterpenoidA diterpenoid based on an abietane skeleton.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (4)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
regulator of G-protein signaling 4Homo sapiens (human)Potency1.06210.531815.435837.6858AID504845
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Transient receptor potential cation channel subfamily V member 1Rattus norvegicus (Norway rat)IC50 (µMol)50.00000.00040.21474.0000AID242413
Oxysterols receptor LXR-betaHomo sapiens (human)IC50 (µMol)50.00000.00790.92859.9000AID242554
Oxysterols receptor LXR-alphaHomo sapiens (human)IC50 (µMol)50.00000.00901.06049.9000AID242413
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Oxysterols receptor LXR-betaHomo sapiens (human)EC50 (µMol)50.00000.00010.40077.3000AID240210; AID403100
Oxysterols receptor LXR-alphaHomo sapiens (human)EC50 (µMol)50.00000.00010.63026.7100AID240218; AID403099
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Other Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Oxysterols receptor LXR-betaHomo sapiens (human)LC5050.00000.02500.75751.4900AID403097
Oxysterols receptor LXR-alphaHomo sapiens (human)LC5050.00000.03500.14250.2500AID403095
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (43)

Processvia Protein(s)Taxonomy
hormone-mediated signaling pathwayOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of triglyceride biosynthetic processOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of cholesterol effluxOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of lipid storageOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of cholesterol storageOxysterols receptor LXR-betaHomo sapiens (human)
intracellular receptor signaling pathwayOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of lipid transportOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of cholesterol transportOxysterols receptor LXR-betaHomo sapiens (human)
phosphatidylcholine acyl-chain remodelingOxysterols receptor LXR-betaHomo sapiens (human)
cholesterol homeostasisOxysterols receptor LXR-betaHomo sapiens (human)
mRNA transcription by RNA polymerase IIOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of fatty acid biosynthetic processOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of proteolysisOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of DNA-templated transcriptionOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of DNA-templated transcriptionOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of pinocytosisOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of lipoprotein lipase activityOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of protein metabolic processOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of high-density lipoprotein particle assemblyOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of pancreatic juice secretionOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of secretion of lysosomal enzymesOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of cold-induced thermogenesisOxysterols receptor LXR-betaHomo sapiens (human)
positive regulation of miRNA transcriptionOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressOxysterols receptor LXR-betaHomo sapiens (human)
cell differentiationOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIOxysterols receptor LXR-betaHomo sapiens (human)
negative regulation of transcription by RNA polymerase IIOxysterols receptor LXR-alphaHomo sapiens (human)
hormone-mediated signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of macrophage derived foam cell differentiationOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of triglyceride biosynthetic processOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of cholesterol effluxOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of cholesterol storageOxysterols receptor LXR-alphaHomo sapiens (human)
intracellular receptor signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of lipid transportOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of cholesterol transportOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of transporter activityOxysterols receptor LXR-alphaHomo sapiens (human)
response to progesteroneOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of toll-like receptor 4 signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
phosphatidylcholine acyl-chain remodelingOxysterols receptor LXR-alphaHomo sapiens (human)
cholesterol homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
regulation of circadian rhythmOxysterols receptor LXR-alphaHomo sapiens (human)
mRNA transcription by RNA polymerase IIOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of macrophage activationOxysterols receptor LXR-alphaHomo sapiens (human)
apoptotic cell clearanceOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of fatty acid biosynthetic processOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of proteolysisOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of DNA-templated transcriptionOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of lipid biosynthetic processOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of pinocytosisOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of inflammatory responseOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of lipoprotein lipase activityOxysterols receptor LXR-alphaHomo sapiens (human)
positive regulation of protein metabolic processOxysterols receptor LXR-alphaHomo sapiens (human)
lipid homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
sterol homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of type II interferon-mediated signaling pathwayOxysterols receptor LXR-alphaHomo sapiens (human)
triglyceride homeostasisOxysterols receptor LXR-alphaHomo sapiens (human)
cellular response to lipopolysaccharideOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of pancreatic juice secretionOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of secretion of lysosomal enzymesOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of cold-induced thermogenesisOxysterols receptor LXR-alphaHomo sapiens (human)
negative regulation of response to endoplasmic reticulum stressOxysterols receptor LXR-alphaHomo sapiens (human)
cell differentiationOxysterols receptor LXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (14)

Processvia Protein(s)Taxonomy
RNA polymerase II cis-regulatory region sequence-specific DNA bindingOxysterols receptor LXR-betaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificOxysterols receptor LXR-betaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificOxysterols receptor LXR-betaHomo sapiens (human)
DNA bindingOxysterols receptor LXR-betaHomo sapiens (human)
protein bindingOxysterols receptor LXR-betaHomo sapiens (human)
zinc ion bindingOxysterols receptor LXR-betaHomo sapiens (human)
chromatin DNA bindingOxysterols receptor LXR-betaHomo sapiens (human)
apolipoprotein A-I receptor bindingOxysterols receptor LXR-betaHomo sapiens (human)
nuclear retinoid X receptor bindingOxysterols receptor LXR-betaHomo sapiens (human)
ATPase bindingOxysterols receptor LXR-betaHomo sapiens (human)
nuclear receptor activityOxysterols receptor LXR-betaHomo sapiens (human)
transcription cis-regulatory region bindingOxysterols receptor LXR-alphaHomo sapiens (human)
transcription cis-regulatory region bindingOxysterols receptor LXR-alphaHomo sapiens (human)
DNA-binding transcription factor activity, RNA polymerase II-specificOxysterols receptor LXR-alphaHomo sapiens (human)
DNA-binding transcription activator activity, RNA polymerase II-specificOxysterols receptor LXR-alphaHomo sapiens (human)
DNA bindingOxysterols receptor LXR-alphaHomo sapiens (human)
nuclear receptor activityOxysterols receptor LXR-alphaHomo sapiens (human)
protein bindingOxysterols receptor LXR-alphaHomo sapiens (human)
zinc ion bindingOxysterols receptor LXR-alphaHomo sapiens (human)
cholesterol bindingOxysterols receptor LXR-alphaHomo sapiens (human)
chromatin DNA bindingOxysterols receptor LXR-alphaHomo sapiens (human)
sterol response element bindingOxysterols receptor LXR-alphaHomo sapiens (human)
RNA polymerase II cis-regulatory region sequence-specific DNA bindingOxysterols receptor LXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (7)

Processvia Protein(s)Taxonomy
nucleusOxysterols receptor LXR-betaHomo sapiens (human)
nucleoplasmOxysterols receptor LXR-betaHomo sapiens (human)
cytoplasmOxysterols receptor LXR-betaHomo sapiens (human)
cytosolOxysterols receptor LXR-betaHomo sapiens (human)
RNA polymerase II transcription regulator complexOxysterols receptor LXR-betaHomo sapiens (human)
chromatinOxysterols receptor LXR-betaHomo sapiens (human)
nucleusOxysterols receptor LXR-betaHomo sapiens (human)
nucleusOxysterols receptor LXR-alphaHomo sapiens (human)
nucleoplasmOxysterols receptor LXR-alphaHomo sapiens (human)
cytoplasmOxysterols receptor LXR-alphaHomo sapiens (human)
cytosolOxysterols receptor LXR-alphaHomo sapiens (human)
RNA polymerase II transcription regulator complexOxysterols receptor LXR-alphaHomo sapiens (human)
chromatinOxysterols receptor LXR-alphaHomo sapiens (human)
receptor complexOxysterols receptor LXR-alphaHomo sapiens (human)
nucleusOxysterols receptor LXR-alphaHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (34)

Assay IDTitleYearJournalArticle
AID588519A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities2011Antiviral research, Sep, Volume: 91, Issue:3
High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors.
AID540299A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis2010Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21
Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
AID157580Cytotoxicity in HPBMC (Human Peripheral Blood Mononuclear Cells); Not tested2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Synthesis of a novel family of diterpenes and their evaluation as anti-inflammatory agents.
AID162968In vitro inhibitory activity against pyruvate dehydrogenase kinase was determined; Inactive at 1 mM concentration1999Bioorganic & medicinal chemistry letters, Aug-02, Volume: 9, Issue:15
Triterpene and diterpene inhibitors of pyruvate dehydrogenase kinase (PDK).
AID403095Displacement of [3H2]F3-methyl AA from human recombinant LXRalpha expressed in Escherichia coli BL21 cells2005Journal of natural products, Aug, Volume: 68, Issue:8
Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources.
AID240218Effective concentration for cofactor association with recombinant liver X receptor-alpha2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.
AID403099Agonist activity at human recombinant LXRalpha expressed in Escherichia coli BL21 cells assessed as association of recombinant SRC1 to LXRalpha ligand binding domain by HTRF assay2005Journal of natural products, Aug, Volume: 68, Issue:8
Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources.
AID1891820Antifungal activity against Candida albicans ATCC 90028 assessed as fungal growth inhibition incubated for 36 hrs by resazurin dye based analysis2022Bioorganic & medicinal chemistry, 06-15, Volume: 64Valorisation of the diterpene podocarpic acid - Antibiotic and antibiotic enhancing activities of polyamine conjugates.
AID1503774Cytotoxicity against human HL cells assessed as cell viability at 50 uM after 72 hrs by resazurin dye based fluorescence assay relative to control2017Journal of natural products, 10-27, Volume: 80, Issue:10
Identification of Privileged Antichlamydial Natural Products by a Ligand-Based Strategy.
AID403097Displacement of [3H2]F3-methyl AA from human recombinant LXRbeta expressed in Escherichia coli BL21 cells2005Journal of natural products, Aug, Volume: 68, Issue:8
Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources.
AID155130Inhibition efficacy of TNF-alpha was tested in HPBMC (Human Peripheral Blood Mononuclear Cells); Not active2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Synthesis of a novel family of diterpenes and their evaluation as anti-inflammatory agents.
AID243348Maximal induction of liver X receptor-alpha receptor in transactivation assay; Not tested2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.
AID155450Inhibition of TNF-alpha was tested in HPBMC (Human Peripheral Blood Mononuclear Cells); Inactive2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Synthesis of a novel family of diterpenes and their evaluation as anti-inflammatory agents.
AID240187Effective concentration against liver X receptor-alpha in HEK293 cell transactivation assay; Not tested2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.
AID90951In vitro effective concentration in normal human dermal fibroblasts; No data1999Bioorganic & medicinal chemistry letters, Aug-02, Volume: 9, Issue:15
Triterpene and diterpene inhibitors of pyruvate dehydrogenase kinase (PDK).
AID242554Displacement of [3H2]-F3-methyl AA (1) from liver X receptor-beta in SPA assay2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.
AID1891815Antibacterial activity against Klebsiella pneumoniae ATCC 700603 assessed as inhibition of bacterial growth measured after 18 hrs by resazurin dye based analysis2022Bioorganic & medicinal chemistry, 06-15, Volume: 64Valorisation of the diterpene podocarpic acid - Antibiotic and antibiotic enhancing activities of polyamine conjugates.
AID240210Effective concentration for cofactor association with recombinant liver X receptor-beta2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.
AID1226071Antiviral activity against oseltamivir/amantadine-resistant Influenza A virus (A/Puerto Rico/8/1934(H1N1)) infected in MDCK cells assessed as protection against virus-induced cytocidal effect after 48 hrs by CellTiter-Glo assay2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Phenolic diterpenoid derivatives as anti-influenza a virus agents.
AID1891817Antibacterial activity against Pseudomonas aeruginosa ATCC 27853 assessed as inhibition of bacterial growth measured after 18 hrs by resazurin dye based analysis2022Bioorganic & medicinal chemistry, 06-15, Volume: 64Valorisation of the diterpene podocarpic acid - Antibiotic and antibiotic enhancing activities of polyamine conjugates.
AID1891818Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as inhibition of bacterial growth measured after 18 hrs by resazurin dye based analysis2022Bioorganic & medicinal chemistry, 06-15, Volume: 64Valorisation of the diterpene podocarpic acid - Antibiotic and antibiotic enhancing activities of polyamine conjugates.
AID1891819Antibacterial activity against Acinetobacter baumannii ATCC 19606 assessed as inhibition of bacterial growth measured after 18 hrs by resazurin dye based analysis2022Bioorganic & medicinal chemistry, 06-15, Volume: 64Valorisation of the diterpene podocarpic acid - Antibiotic and antibiotic enhancing activities of polyamine conjugates.
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1891821Antifungal activity against Cryptococcus neoformans ATCC 208821 assessed as fungal growth inhibition incubated for 36 hrs by resazurin dye based analysis2022Bioorganic & medicinal chemistry, 06-15, Volume: 64Valorisation of the diterpene podocarpic acid - Antibiotic and antibiotic enhancing activities of polyamine conjugates.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID1891816Antibacterial activity against Escherichia coli ATCC 25922 assessed as inhibition of bacterial growth measured after 18 hrs by resazurin dye based analysis2022Bioorganic & medicinal chemistry, 06-15, Volume: 64Valorisation of the diterpene podocarpic acid - Antibiotic and antibiotic enhancing activities of polyamine conjugates.
AID242413Displacement of [3H2]-F3-methyl AA (1) from liver X receptor-alpha in SPA assay2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.
AID243347Maximal induction of liver X receptor-beta receptor in transactivation assay; Not tested2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.
AID387725Activation of human BKalpha channel expressed in CHOK1 cells assessed as increase in ionic current at 30 uM relative to control2008Bioorganic & medicinal chemistry letters, Oct-01, Volume: 18, Issue:19
Design, synthesis and characterization of podocarpate derivatives as openers of BK channels.
AID1226072Cytotoxicity against MDCK cells assessed as reduction of cell viability2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Phenolic diterpenoid derivatives as anti-influenza a virus agents.
AID1226073Antiviral activity against oseltamivir-sensitive Influenza A virus (A/Hong Kong/8/68(H3N2)) infected in MDCK cells assessed as protection against virus-induced cytocidal effect at 20 uM after 48 hrs by CellTiter-Glo assay relative to control2015ACS medicinal chemistry letters, Mar-12, Volume: 6, Issue:3
Phenolic diterpenoid derivatives as anti-influenza a virus agents.
AID403100Agonist activity at human recombinant LXRbeta expressed in Escherichia coli BL21 cells assessed as association of recombinant SRC1 to LXRbeta ligand binding domain by HTRF assay2005Journal of natural products, Aug, Volume: 68, Issue:8
Diterpenoid, steroid, and triterpenoid agonists of liver X receptors from diversified terrestrial plants and marine sources.
AID155127Cytotoxicity in HPBMC (Human Peripheral Blood Mononuclear Cells); Not active2003Bioorganic & medicinal chemistry letters, Oct-06, Volume: 13, Issue:19
Synthesis of a novel family of diterpenes and their evaluation as anti-inflammatory agents.
AID240177Effective concentration against liver X receptor-beta in HEK293 transactivation assay; Not tested2005Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
Discovery and development of dimeric podocarpic acid leads as potent agonists of liver X receptor with HDL cholesterol raising activity in mice and hamsters.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (11.54)18.7374
1990's5 (19.23)18.2507
2000's7 (26.92)29.6817
2010's10 (38.46)24.3611
2020's1 (3.85)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.09

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.09 (24.57)
Research Supply Index3.30 (2.92)
Research Growth Index4.75 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.09)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (7.69%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other24 (92.31%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]